Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 11/20 | 0.51 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.45 |
| ▸ | PIM1 | P11309 | 2/20 | 0.41 |
| ▸ | HASPIN | Q8TF76 | 2/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.37 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.37 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625227 | 0.94 | PIK3CA (0.55) | PIK3CAKCNH2PIM1HASPINMTOR | |
| SCHEMBL627410 | 0.88 | PIK3CA (0.57) | PIK3CAKCNH2PIM1HASPINMTOR | |
| SCHEMBL625201 | 0.88 | PIK3CA (0.48) | PIK3CAKCNH2HASPIN | |
| SCHEMBL626391 | 0.87 | PIK3CA (0.48) | PIK3CAKCNH2 | |
| SCHEMBL625222 | 0.87 | PIK3CA (0.48) | PIK3CAKCNH2PIK3CDPIK3CBPIK3CG | |
| SCHEMBL625019 | 0.85 | MAP3K12 (0.45) | — | |
| SCHEMBL625177 | 0.84 | PIK3CA (0.49) | PIK3CAKCNH2PIK3CD | |
| SCHEMBL624865 | 0.84 | PIK3CA (0.49) | PIK3CAKCNH2PIK3CDPIK3CBPIK3CG | |
| SCHEMBL624869 | 0.83 | PIK3CA (0.52) | PIK3CAKCNH2HASPINPIK3CDPIK3CB | |
| SCHEMBL625620 | 0.83 | PIK3CA (0.56) | PIK3CAKCNH2PIM1HASPIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |